Patient2020-03-23T16:48:32+00:00

THIS PAGE IS INTENDED FOR UK PATIENTS WHO HAVE BEEN PRESCRIBED Gatalin XL
GatNewBanner

Gatalin XL

Gatalin® XL Patient Information
This link will take you to the electronic Medicines Compendium (eMC) website.

Gatalin® XL Patient Information

Gatalin® XL Summary of Product Characteristics
These links will take you to the electronic Medicines Compendium (eMC) website:

8mg prolonged-release capsules:

16mg prolonged-release capsules:

24mg prolonged-release capsules:

Alzheimer’s Disease Resources

Please click the links below to leave the Aspire Pharma website. Aspire are not responsible for the content of external sites.

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the product’s package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
Revision reference – Gatalin XL_23_23.03.2020